ABVC Biopharma Inc Long-term Investment Intensity
ABVC Biopharma Inc long-term investment intensity. ABVC Biopharma Inc (ABVC) has a Long-term Investment Intensity of 12.8% as of June 2026. Long-term investments of $2.49 Million represent 12.8% of total assets of $19.40 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read ABVC liabilities breakdown for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of ABVC Biopharma Inc (2017–2025)
Long-term investment intensity of ABVC Biopharma Inc from 2017 to 2025. This chart shows how ABVC Biopharma Inc's Long-term Investment Intensity has evolved across 8 annual periods from 2017 to 2025. As of June 2026, the intensity stands at 12.8%, reflecting long-term investments of $2.49 Million against total assets of $19.40 Million USD.
ABVC Biopharma Inc Long-term Investment Intensity by Year (2017–2025)
ABVC Biopharma Inc long-term investment intensity by year from 2017 to 2025. The table below presents the year-by-year Long-term Investment Intensity for ABVC Biopharma Inc from 2017 to 2025, covering 8 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see ABVC Biopharma Inc total assets.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 8.9% | $1.88 Million | $21.06 Million | ▼ -21.0 pp |
| 2024 | 30.0% | $2.26 Million | $7.54 Million | ▼ -2.5 pp |
| 2023 | 32.5% | $2.53 Million | $7.78 Million | ▲ +24.8 pp |
| 2022 | 7.7% | $842.07K | $10.93 Million | ▲ +0.9 pp |
| 2021 | 6.8% | $932.75K | $13.70 Million | ▼ -1.3 pp |
| 2020 | 8.1% | $1.19 Million | $14.77 Million | ▼ -40.5 pp |
| 2019 | 48.6% | $3.36 Million | $6.93 Million | ▼ -14.8 pp |
| 2017 | 63.4% | $4.19 Million | $6.60 Million | — |